Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
TriCore Contact:
|
|||
Dr. Nick Dayan
Chief Administrative Officer
(505) 938-8991
TriCore Announces Dr. Michael Crossey as Chief Executive Officer & President
For Immediate Release (Albuquerque, New Mexico) - March 6, 2018 – TriCore Reference Laboratories is pleased to announce that the board of directors has appointed Michael Crossey, MD, PhD, to the position of CEO and president, effective immediately.
Dr. Crossey’s appointment is a clear reflection of the company’s current state: Ready to take on the future! Robin Divine, chair of TriCore’s board of directors, stated: “Enormous opportunity for TriCore lies ahead. We couldn’t be happier with Dr. Crossey accepting this position and moving us down the path of continued success.”
For the past 20 years since TriCore’s inception, Dr. Crossey has served the organization in various capacities, from pathologist to chief medical officer to interim chief executive officer. He brings decades of experience and internationally recognized expertise in clinical laboratory medicine to the company.
Says Dr. Crossey of his new position: “I'm honored, and I'm grateful to the board for the opportunity to lead this exceptional organization of creative, dedicated and talented professionals."
###
TriCore Reference Laboratories is an independent, not-for-profit, clinical reference laboratory founded and headquartered in Albuquerque, New Mexico, co-sponsored by Presbyterian Healthcare Services and University of New Mexico Health Sciences Center. TriCore provides over 2,900, full-service, state-of-the-art laboratory tests to healthcare professionals and their patients. TriCore also provides analytics and research services, supporting healthcare and scientific organizations worldwide.
For more information, visit tricore.org.
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/68207f80-51fb-4664-84de-80bee403f3fc
Nick Dayan TriCore Reference Laboratories 5059388991 [email protected]
